Phase I-II Trial of Glasdegib in Myelofibrosis - Glasdegib is a Hedgehog Pathway Inhibitor

Phase I-II Trial of Glasdegib in Myelofibrosis - Glasdegib is a Hedgehog Pathway Inhibitor

User Photo
ASHReport

3 years
624 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aaron Gerds, MD from Cleveland Clinics discusses phase I-II trial of Glasdegib in myelofibrosis and that Glasdegib is a Hedgehog Pathway Inhibitor at the 2017 American Society of Hematology.
Up Next Autoplay
>